Stemina Biomarker Discovery Selects CallidusCloud Marketing Automation

Stemina Biomarker Discovery Selects CallidusCloud Marketing Automation

DUBLIN, CA — (Marketwired) — 06/08/16 — (NASDAQ: CALD), a global leader in cloud-based , , and solutions, announced today that a biomarker discovery company focused on diagnosis and individualized treatment of neurological disorders, has selected CallidusCloud .Marketing Automation is delivered as part of CallidusCloud–s Lead to Money suite, a SaaS suite designed to help businesses drive , and throughout the sales cycle to close bigger deals, faster.Callidus Software Inc. (NASDAQ: CAL

1 82 83 84 85 86 114